新闻中心
News Center
2019-Fangu Public Welfare-Caring for the poor mentally ill
Release Time
2022-06-21 16:19
Adhering to public welfare, repaying the society, and spreading love are the philosophy of Foncoo Public Welfare.
In September 2019, Longnan Foncoo , a subsidiary of Fangu Pharmaceutical Co., Ltd., through the Longnan Town People's Government and the Longnan County Red Cross Society, sent financial assistance to some poor families of mentally ill patients in Longnan Town to help solve the problems of drug use and living difficulties. The total 50,000 yuan. The company continues its public welfare undertakings, hoping that the trickle of love will gather into a river, sow the seeds of love, ignite the lonely heart lamp, and send more warmth to the families who are struggling with the disease, as well as the courage to continue to fight against the disease.
In September 2019, Longnan Foncoo , a subsidiary of Fangu Pharmaceutical Co., Ltd., through the Longnan Town People's Government and the Longnan County Red Cross Society, sent financial assistance to some poor families of mentally ill patients in Longnan Town to help solve the problems of drug use and living difficulties. The total 50,000 yuan. The company continues its public welfare undertakings, hoping that the trickle of love will gather into a river, sow the seeds of love, ignite the lonely heart lamp, and send more warmth to the families who are struggling with the disease, as well as the courage to continue to fight against the disease.
Related News
Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.
2022-05-25
On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.
2022-05-25
Foncoo Pharmaceutical's corporate culture 5.0 was officially released
Official announcement! Seriously, don't be distracted!
2022-05-25
On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.
2022-05-25
Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.
2022-05-25
Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum
From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".
2022-05-25
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No.1001 Xue Yuan Boulevard, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED